BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 30013556)

  • 21. Basic techniques for studies of iNKT cells and MAIT cells.
    Chiba A; Miyake S
    Methods Mol Biol; 2014; 1142():75-84. PubMed ID: 24706277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
    Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
    J Biol Chem; 2024 May; 300(6):107338. PubMed ID: 38705391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent
    Paquin-Proulx D; Costa PR; Terrassani Silveira CG; Marmorato MP; Cerqueira NB; Sutton MS; O'Connor SL; Carvalho KI; Nixon DF; Kallas EG
    Front Immunol; 2018; 9():1394. PubMed ID: 29971068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
    Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
    PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers.
    Rahimpour A; Koay HF; Enders A; Clanchy R; Eckle SB; Meehan B; Chen Z; Whittle B; Liu L; Fairlie DP; Goodnow CC; McCluskey J; Rossjohn J; Uldrich AP; Pellicci DG; Godfrey DI
    J Exp Med; 2015 Jun; 212(7):1095-108. PubMed ID: 26101265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease.
    Marrero I; Maricic I; Morgan TR; Stolz AA; Schnabl B; Liu ZX; Tsukamoto H; Kumar V
    Alcohol Clin Exp Res; 2020 May; 44(5):1061-1074. PubMed ID: 32154597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?
    Pisarska MM; Dunne MR; O'Shea D; Hogan AE
    Eur J Immunol; 2020 Aug; 50(8):1098-1108. PubMed ID: 32617963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, γδ T cells, and mucosa-associated invariant T cells.
    Singh P; Szaraz-Szeles M; Mezei Z; Barath S; Hevessy Z
    Geroscience; 2022 Aug; 44(4):2047-2060. PubMed ID: 35038082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of Mucosal-Associated Invariant T Cells in TCRJα18 Germline Knockout Mice.
    Xie J; Pan Y; Tao H; Wang P; Chen Y; Gao J; Zhong XP
    Immunohorizons; 2019 Jun; 3(6):203-207. PubMed ID: 31356166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
    Yao T; Rudak PT; Laumont CM; Michaud AR; Rashu R; Knier NN; Foster PJ; McWilliam HEG; Villadangos JA; Nelson BH; DiMattia GE; Shepherd TG; Haeryfar SMM
    Cancer Immunol Immunother; 2022 May; 71(5):1259-1273. PubMed ID: 34854949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment.
    Chandra S; Wingender G; Greenbaum JA; Khurana A; Gholami AM; Ganesan AP; Rosenbach M; Jaffee K; Gern JE; Wood R; O'Connor G; Sandel M; Kattan M; Bacharier L; Togias A; Horner AA; Kronenberg M
    J Immunol; 2018 Mar; 200(6):1995-2003. PubMed ID: 29431692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
    Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mucosal-associated invariant T cells in infectious diseases.
    Wong EB; Ndung'u T; Kasprowicz VO
    Immunology; 2017 Jan; 150(1):45-54. PubMed ID: 27633333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal-Associated Invariant T Cells in Autoimmune Diseases.
    Chiba A; Murayama G; Miyake S
    Front Immunol; 2018; 9():1333. PubMed ID: 29942318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAIT Cells: Partners or Enemies in Cancer Immunotherapy?
    Cogswell DT; Gapin L; Tobin HM; McCarter MD; Tobin RP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.
    Shissler SC; Lee MS; Webb TJ
    Front Immunol; 2017; 8():1447. PubMed ID: 29163518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
    Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
    JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.